APOE and Alzheimer disease: The APOE ε4 allele was significantly more frequent in both the high AD group (in 54% vs 5% of the subjects, p < 0.001) and low AD group (in 28% vs 5% of the subjects, 0.001 ≤ p < 0.01) compared with the PART group (Table 3).